LabCorp(R) and DIANON Announce Expiration of Antitrust Waiting Period for LabCorp's Proposed Acquisition of DIANON

BURLINGTON, N.C., and STRATFORD, Conn., Dec. 24 /PRNewswire-FirstCall/ Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) and Dianon Systems, Inc. (Nasdaq: DIAN) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to

LabCorp(R) Scheduled to Present at the Merrill Lynch Health Services Investor Conference

BURLINGTON, N.C., Dec. 2 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs and licensing, is scheduled to speak at the Merrill Lynch Health Services Investor Conference

LabCorp(R) Scheduled to Present at the Credit Suisse First Boston Health Care Conference

BURLINGTON, N.C., Nov. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the CSFB Health Care Conference in Phoenix, AZ on November 14, 2002 at

Laboratory Corporation of America(R) Announces Definitive Agreement To Acquire DIANON Systems, Inc

BURLINGTON, N.C., and Stratford, Conn., Nov. 11 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and DIANON Systems, Inc. (Nasdaq: DIAN), a leading provider of cancer and genomic diagnostic services, today announced that they have entered into a

LabCorp(R) Scheduled to Present at the CIBC World Markets Health Care Conference

BURLINGTON, N.C., Nov 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the CIBC World Markets Health Care Conference in New

Laboratory Corporation of America(R) Announces Third Quarter Results

BURLINGTON, N.C., Oct 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- Genomic Testing Drives Revenue Growth of 16.8 Percent, EBITDA Margins of 22.3 Percent and Strong Cash Flow Increases Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced results for the quarter and

LabCorp(R) Scheduled to Present at the Salomon Smith Barney Global Health Care Conference

BURLINGTON, N.C., Oct 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Salomon Smith Barney Global Health Care Conference

LabCorp(R) Announces Stock Repurchase Program

BURLINGTON, N.C., Oct 22, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized a stock repurchase program under which LabCorp may purchase up to an aggregate of $150,000,000 of its

LabCorp(R) Scheduled to Present at UBS Warburg Global Life Sciences Conference

BURLINGTON, N.C., Oct 4, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the UBS Warburg Global Life Sciences Conference on

Labcorp(R) Reports Preliminary Third Quarter Results

BURLINGTON, N.C., Oct 3, 2002 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced, based on a preliminary projection of third quarter results, that it expects revenues for the quarter ended September 30, 2002, to be in the range